SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001654954-18-011384
Filing Date
2018-10-19
Accepted
2018-10-19 10:44:59
Documents
42
Period of Report
2018-08-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT qbiomed10-q.htm 10-Q/A 565776
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit311.htm EX-31.1 19232
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit321.htm EX-32.1 8486
  Complete submission text file 0001654954-18-011384.txt   1761869

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20180831.xml EX-101.INS 212347
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20180831.xsd EX-101.SCH 20242
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20180831_cal.xml EX-101.CAL 26371
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20180831_def.xml EX-101.DEF 23174
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20180831_lab.xml EX-101.LAB 142663
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20180831_pre.xml EX-101.PRE 101697
Mailing Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017
Business Address 366 MADISON AVE. 3RD FLOOR NEW YORK NY 10017 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q/A | Act: 34 | File No.: 000-55535 | Film No.: 181129621
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences